BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3312442)

  • 1. Fibronectin gelatin-binding activity: effects of platelet thrombospondin, serum, and plasma.
    Gelder FB; Brown ST
    J Lab Clin Med; 1987 Nov; 110(5):548-57. PubMed ID: 3312442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of thrombospondin as a high molecular mass protein released from activated equine platelets.
    Lipscomb DL; Boudreaux MK; Paxton R; Spano J; Welles EG; Schumacher J
    Am J Vet Res; 1997 Sep; 58(9):954-60. PubMed ID: 9284998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a new kinetic assay for the quantitation of fibronectin gelatin-binding activity.
    Gelder FB; Brown ST; Moore CA
    J Lab Clin Med; 1985 Oct; 106(4):416-23. PubMed ID: 4045297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantitation of platelet-associated fibronectin antigen.
    Plow EF; Birdwell C; Ginsberg MH
    J Clin Invest; 1979 Mar; 63(3):540-3. PubMed ID: 372243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding.
    Lahav J; Lawler J; Gimbrone MA
    Eur J Biochem; 1984 Nov; 145(1):151-6. PubMed ID: 6489349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An altered platelet granule glycoprotein in patients with essential thrombocythemia.
    Booth WJ; Berndt MC; Castaldi PA
    J Clin Invest; 1984 Feb; 73(2):291-7. PubMed ID: 6365970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-thrombospondin antibodies on the hemagglutination activities of the endogenous platelet lectin and thrombospondin.
    Gartner TK; Doyle MJ; Mosher DF
    Thromb Haemost; 1984 Dec; 52(3):354-7. PubMed ID: 6442473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do extra-platelet sources contribute to the plasma level of thrombospondin?
    Dawes J; Pratt DA; Dewar MS; Preston FE
    Thromb Haemost; 1988 Apr; 59(2):273-6. PubMed ID: 2968680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin.
    Sipes JM; Guo N; Nègre E; Vogel T; Krutzsch HC; Roberts DD
    J Cell Biol; 1993 Apr; 121(2):469-77. PubMed ID: 8468356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the interaction between human plasma fibronectin and gelatin by affinity electrophoresis.
    Kashiwagi S; Nakamura K; Takeo K; Takasago T; Uchimichi A; Ito H
    Electrophoresis; 1991 Jun; 12(6):420-4. PubMed ID: 1889390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of two binding domains for thrombospondin within fibronectin.
    Zafar RS; Zeng Z; Walz DA
    Arch Biochem Biophys; 1992 Sep; 297(2):271-6. PubMed ID: 1497347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of macrophage agglutination factor activity to the gelatin-binding domain of fibronectin.
    Godfrey HP; Angadi CV; Wolstencroft RA; Bianco C
    J Immunol; 1984 Sep; 133(3):1417-23. PubMed ID: 6086756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a 25kDal, fibronectin-binding, mitogenic peptide from bovine plasma.
    Channon KM; Ayad SR
    Anticancer Res; 1986; 6(6):1377-84. PubMed ID: 2949690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of the opsonic activity of fibronectin by a plasma factor lacking gelatin affinity.
    Blumenstock FA; Saba TM; Cardarelli PM; Cho E
    J Reticuloendothel Soc; 1983 Jan; 33(1):21-33. PubMed ID: 6834358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin.
    Kao KJ; Shaut DM; Klein PA
    Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen.
    Lahav J; Schwartz MA; Hynes RO
    Cell; 1982 Nov; 31(1):253-62. PubMed ID: 7159924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.